Erythropoietin Completed Phase 3 Trials for Multiple Myeloma and Plasma Cell Neoplasm / Anemias / Malignant Lymphomas / Leukemias Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care3
clinicaltrials.gov IdentifierTitleDrugs
NCT00003341Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy